JP2008526749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526749A5 JP2008526749A5 JP2007549507A JP2007549507A JP2008526749A5 JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5 JP 2007549507 A JP2007549507 A JP 2007549507A JP 2007549507 A JP2007549507 A JP 2007549507A JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- membrane
- pharmaceutical composition
- self
- biologically compatible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 239000012528 membrane Substances 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000001768 cations Chemical class 0.000 claims 5
- 229910052751 metal Inorganic materials 0.000 claims 5
- 239000002184 metal Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 238000001338 self-assembly Methods 0.000 claims 3
- 239000012736 aqueous medium Substances 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- VVNXEADCOVSAER-UHFFFAOYSA-N lithium sodium Chemical compound [Li].[Na] VVNXEADCOVSAER-UHFFFAOYSA-N 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 210000000944 nerve tissue Anatomy 0.000 claims 1
- 108010091748 peptide A Proteins 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64099805P | 2005-01-04 | 2005-01-04 | |
| US70231805P | 2005-07-26 | 2005-07-26 | |
| PCT/US2005/046768 WO2006073889A2 (en) | 2005-01-04 | 2005-12-29 | Sustained delivery of pdgf using self-assembling peptide nanofibers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526749A JP2008526749A (ja) | 2008-07-24 |
| JP2008526749A5 true JP2008526749A5 (enExample) | 2009-01-22 |
Family
ID=36648006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549507A Pending JP2008526749A (ja) | 2005-01-04 | 2005-12-29 | 自己アセンブリするペプチドナノファイバーを用いたｐｄｇｆの徐放性の送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7429567B2 (enExample) |
| EP (1) | EP1833504A4 (enExample) |
| JP (1) | JP2008526749A (enExample) |
| AU (1) | AU2005323062A1 (enExample) |
| CA (1) | CA2592292A1 (enExample) |
| WO (1) | WO2006073889A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4023240A1 (en) * | 2004-07-06 | 2022-07-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US9162005B2 (en) * | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
| US9327010B2 (en) | 2005-04-25 | 2016-05-03 | Massachusetts Institute Of Technology | Compositions and methods for promoting hemostasis and other physiological activities |
| CN101472620A (zh) | 2006-04-25 | 2009-07-01 | 麻省理工学院 | 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法 |
| EP2502628B1 (en) * | 2006-06-23 | 2016-12-14 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
| US8022178B2 (en) * | 2006-09-26 | 2011-09-20 | Massachusetts Institute Of Technology | Modified self-assembling peptides |
| US7696309B2 (en) | 2006-10-23 | 2010-04-13 | The Brigham And Women's Hospital, Inc. | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| US9187517B2 (en) | 2006-11-13 | 2015-11-17 | The Brigham And Women's Hospital, Inc. | Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| DK2089047T3 (da) * | 2006-12-11 | 2013-02-18 | 3D Matrix Inc | Sammensætninger og fremgangsmåder til beskyttelse og regenerering af hjerte-væv |
| DK2146733T3 (da) * | 2007-03-14 | 2021-01-11 | Arch Biosurgery Inc | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| EP2345433B1 (en) | 2008-10-06 | 2017-03-01 | 3-D Matrix, Ltd. | Tissue plug |
| WO2010060186A1 (en) | 2008-11-03 | 2010-06-03 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| US20110117195A1 (en) * | 2009-11-18 | 2011-05-19 | National Cheng Kung University | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| US9439941B2 (en) | 2009-12-14 | 2016-09-13 | The University Of Hong Kong | Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells |
| JP5732691B2 (ja) * | 2010-01-14 | 2015-06-10 | 学校法人同志社 | インスリン製剤 |
| US9308277B2 (en) | 2010-02-25 | 2016-04-12 | Mesoblast International Sàrl | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| DK3173427T3 (da) | 2011-03-31 | 2019-08-05 | Adc Therapeutics Sa | Antistoffer mod nyre-associeret antigen 1 og antigen-bindende fragmenter deraf |
| US10662234B2 (en) | 2011-06-07 | 2020-05-26 | Mesoblast International Sàrl | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 |
| HRP20190946T1 (hr) | 2012-01-09 | 2019-07-26 | Adc Therapeutics Sa | Sredstva za liječenje trostruko negativnog raka dojke |
| US9790264B2 (en) | 2012-06-25 | 2017-10-17 | The Brigham And Women's Hospital, Inc. | Compounds and methods for modulating pharmacokinetics |
| WO2014004467A1 (en) | 2012-06-25 | 2014-01-03 | The Brigham And Women's Hospital, Inc. | Selective cartilage therapy |
| WO2014004465A1 (en) | 2012-06-25 | 2014-01-03 | The Brigham And Women's Hospital, Inc. | Targeted therapeutics |
| JP6389170B2 (ja) | 2012-07-06 | 2018-09-12 | スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． | ペプチド溶液のためのフィル−フィニッシュ過程 |
| EP2698162A1 (en) | 2012-08-15 | 2014-02-19 | Credentis AG | Method for producing a composition for treating a tooth lesion |
| US10130735B2 (en) * | 2012-09-21 | 2018-11-20 | Technologias Avanzadas Inspiralia S.L. | Scaffold for cardiac patch |
| CN105658252A (zh) | 2013-08-22 | 2016-06-08 | 阿奇生物外科有限公司 | 用于控制流体移动的可植入网状物 |
| AU2014327234B2 (en) | 2013-09-25 | 2019-02-21 | Credentis Ag | Dental care product for tooth whitening |
| EP2853256A1 (en) | 2013-09-25 | 2015-04-01 | Credentis AG | Dental care product for tooth whitening |
| JP6684719B2 (ja) | 2014-03-10 | 2020-04-22 | 株式会社スリー・ディー・マトリックス | ペプチド組成物の滅菌および濾過 |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| CA2939696C (en) | 2014-03-10 | 2023-01-10 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
| CN104497107B (zh) * | 2014-12-08 | 2017-09-19 | 重庆医科大学 | 一种自组装短肽及其在细胞三维培养中的应用 |
| CN104693277B (zh) * | 2015-03-26 | 2018-02-13 | 罗忠礼 | 一种自组装短肽及其在细胞三维培养中的应用 |
| CN105148289B (zh) * | 2015-09-30 | 2018-10-09 | 南京中医药大学 | 一种两亲性寡聚多肽药物结合物 |
| CN105288653B (zh) * | 2015-11-19 | 2018-10-09 | 南京中医药大学 | 一种两亲性寡聚多肽药物结合物 |
| WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| EP3248591A1 (en) | 2016-05-24 | 2017-11-29 | Credentis AG | Method and product for caries treatment |
| EP3248590A1 (en) | 2016-05-24 | 2017-11-29 | Credentis AG | Personal dental care product for caries treatment |
| EP3723726A1 (en) | 2017-12-15 | 2020-10-21 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses in drug delivery |
| WO2020171161A1 (ja) * | 2019-02-20 | 2020-08-27 | 国立大学法人東京農工大学 | 自己組織化ペプチド |
| EP3831360A1 (en) | 2019-12-04 | 2021-06-09 | Credentis AG | Personal dental care product for preventing demineralisation |
| US11154470B1 (en) | 2020-07-31 | 2021-10-26 | vVardis AG | Anti-inflammatory and senolytic dental care product with tooth whitening characteristics |
| CN114181295B (zh) * | 2021-12-15 | 2023-07-04 | 湖南大学 | 一种多肽衍生物及其用途、水凝胶及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670483A (en) | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| EP0697883A1 (en) * | 1993-04-29 | 1996-02-28 | Washington University | Use of platelet-derived growth factor to improve collateral circulation |
| EP0832269A1 (en) * | 1995-06-07 | 1998-04-01 | Baylor College Of Medicine | Nucleic acid transporters for delivery of nucleic acids into a cell |
| WO2001035932A2 (en) * | 1999-11-18 | 2001-05-25 | The Regents Of The University Of Michigan | Sustained drug delivery from structural matrices |
| ATE419333T1 (de) * | 2001-02-06 | 2009-01-15 | Massachusetts Inst Technology | Peptidgerüstverkapselung von gewebszellen und verwendungen davon |
| US7449180B2 (en) * | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| CA2440387A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| WO2003006043A1 (en) * | 2001-07-10 | 2003-01-23 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| US20040105839A1 (en) * | 2001-11-28 | 2004-06-03 | Myung-Ok Park | Biologically active non-antigenic copolymer and conjugates thereof and methods for producing the same |
| US20030139333A1 (en) * | 2002-01-18 | 2003-07-24 | Genetix Pharmaceuticals, Inc. | Methods and compositions for promoting angiogenesis |
| WO2003096972A2 (en) * | 2002-05-13 | 2003-11-27 | Massachusetts Institute Of Technology | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| WO2004007683A2 (en) * | 2002-07-15 | 2004-01-22 | Massachusetts Institute Of Technology | Cellular reprogramming in peptide hydrogel and uses thereof |
| JP2004115413A (ja) * | 2002-09-25 | 2004-04-15 | Yasuhiko Tabata | 冠状動脈狭窄または閉塞治療用徐放性製剤 |
| WO2004045531A2 (en) * | 2002-11-14 | 2004-06-03 | Cornell Research Foundation, Inc. | Protection of cardiac myocardium |
| US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
| US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| DK1636250T3 (en) * | 2003-06-25 | 2016-02-22 | Massachusetts Inst Technology | SELF-ORGANIZING PEPTIDES, CONTAINING MODIFICATIONS, AND APPLICATIONS THEREOF |
| EP4023240A1 (en) * | 2004-07-06 | 2022-07-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
-
2005
- 2005-12-29 US US11/320,468 patent/US7429567B2/en not_active Expired - Fee Related
- 2005-12-29 EP EP05855348A patent/EP1833504A4/en not_active Withdrawn
- 2005-12-29 JP JP2007549507A patent/JP2008526749A/ja active Pending
- 2005-12-29 AU AU2005323062A patent/AU2005323062A1/en not_active Abandoned
- 2005-12-29 CA CA002592292A patent/CA2592292A1/en not_active Abandoned
- 2005-12-29 WO PCT/US2005/046768 patent/WO2006073889A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526749A5 (enExample) | ||
| TWI480069B (zh) | 用以改善心肌梗塞之醫藥組成物 | |
| JP2008505919A5 (enExample) | ||
| JP2005506340A5 (enExample) | ||
| CN1191826C (zh) | 药物制剂 | |
| JP4095557B2 (ja) | 尿酸を削減するためのヒスチジンおよびアラニンのジペプチドを含有する組成物および尿酸を削減するための医薬の製造のためのジペプチドの使用 | |
| ES2487493T3 (es) | Formulaciones orales de glicil-2-metilprolil-glutamato | |
| US20200339990A1 (en) | RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF | |
| CA2452923A1 (en) | Peptide-based compounds for targeting integrin receptors | |
| RU99118890A (ru) | Водорастворимая фармацевтическая композиция в виде ионного комплекса и ее применение | |
| CN1956735A (zh) | 用于增强治疗剂黏膜吸收的递送剂 | |
| CN104395391A (zh) | 双重衍生化的壳聚糖纳米粒子以及制造和使用其用于体内基因转移的方法 | |
| CN1879888B (zh) | 透皮给药增强剂及其使用方法 | |
| JP2006199589A (ja) | 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤 | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP7265303B2 (ja) | テリパラチドを含む経口用薬学組成物及びその製造方法 | |
| CN112826794B (zh) | 一种靶向修复神经血管病变的纳米复合物及其制备与应用 | |
| EP2194970A2 (en) | Enhancement of the efficacy of therapeutic proteins | |
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| ES2822598T3 (es) | Métodos y composiciones para tratar enfermedades y trastornos musculares | |
| RU2011131772A (ru) | Генерируемые в результате инсульта усилители ангиогенеза и их применение | |
| ES2296529A1 (es) | Composicion farmaceutica con promotores de absorcion. | |
| JP2011084581A (ja) | 経鼻投与用医薬組成物 | |
| JP4931306B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| CN1222310C (zh) | 肝实质细胞增殖因子药用制剂 |